EMA panel recommends extending indication for Novartis'' Revolade drug
The European Union drug regulator''s human medicines committee has recommended extending the indication for Novartis'' (NVS) receptor agonist Revolade
EMA panel recommends extending indication for Novartis'' Revolade drug
The European Union drug regulator''s human medicines committee has recommended extending the indication for Novartis'' (NVS) receptor agonist Revolade